|
Announcements
CONCEPTUS
INC. SELECTS CLINIVATION WORLDVIEW®. Innovator
in the design, development, promotion and distribution of medical products for
use in the field of women's health selects clinivation WorldView as their enterprise
solution for on-demand global regulatory intelligence. Natick,
MA, May 21, 2009 - clinivation, Inc. announced today that Conceptus, Inc.
has selected the clinivation WorldView enterprise solution for On-Demand Global
Regulatory Intelligence.
"Conceptus is a leader in the design, development
and marketing of innovative solutions in women's healthcare. We are pleased that
they have chosen clinivation WorldView for comprehensive, authoritative, and up-to-date
global regulatory intelligence," said Richard Morroney, R.A.C., C.Q.A., clinivation's
Vice President, Global Market Clearance Solutions. About
clinivation WorldView On-Demand Global Regulatory Intelligence
Clinivation WorldView is the medical device and diagnostic industry's most comprehensive,
authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory
Intelligence. Providing clear, step-by-step market clearance regulations, processes,
and guidance for >99% of the world markets, only clinivation WorldView delivers
tried-and-true intelligence from certified, practicing professionals with real-world
experience. About Conceptus, Inc.
Conceptus, Inc. designs, develops, and markets minimally invasive devices for
reproductive medical applications in the United States. The company offers Essure,
a permanent birth control system for women. The Essure system uses a micro-insert
that is delivered into a woman's fallopian tubes to provide permanent birth control
by causing a benign tissue in-growth that blocks the fallopian tubes. The company
distributes its products through direct sales force and distributor networks,
as well as media, including television, radio, direct mail, and print to gynecologists
and general practitioners. Conceptus, Inc. was founded in 1992 and is headquartered
in Mountain View, California. For more information, please visit www.conceptus.com.
About clinivation, Inc. Clinivation
is the leading provider of integrated solutions that enable global market clearance.
Guided by our singular vision - "Excellence in Market Clearance" - clinivation
accelerates the entire market clearance cycle to advance new worldwide revenue
and achieve new milestones of enterprise value. Used in over 1,000,000 product
registrations by more than 100 companies worldwide, clinivation's end-to-end technology
and services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance. The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code. Our core brands include the clinivation Global xi
market clearance platform, clinivation WorldView on-demand regulatory intelligence,
and clinivation Clinical Suite and clinivation Registry Suite electronic data
capture and clinical data management software. Founded in 1999, the company
is headquartered in Natick, Massachusetts, with regional offices in North America
and Asia. Visit clinivation online at www.clinivation.com For
further information: For more information on clinivation's
integrated solutions that enable global market clearance, please click
here or call us at 508.655.6560. |
